Cargando…
Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo
Key metabolic enzymes regulatethe fluxes of small compounds to provide the basal substrates for cellular architecture and energy. Some of them are reported to be important carcinogenesis- and metastasis-related genes. In our work, we performed RNA-seq for50 pairs of normal-tumor of hepatocellular ca...
Autores principales: | Liu, Gang, Hou, Guojun, Li, Liang, Li, Yixue, Zhou, Weiping, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078037/ https://www.ncbi.nlm.nih.gov/pubmed/27119355 http://dx.doi.org/10.18632/oncotarget.8927 |
Ejemplares similares
-
Dimethylglycine Deficiency and the Development of Diabetes
por: Magnusson, Martin, et al.
Publicado: (2015) -
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
por: Hou, Guojun, et al.
Publicado: (2016) -
Structure and biochemical properties of recombinant human dimethylglycine dehydrogenase and comparison to the disease‐related H109R variant
por: Augustin, Peter, et al.
Publicado: (2016) -
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma
por: Liu, Xiangye, et al.
Publicado: (2020) -
EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
por: Gu, Fangming, et al.
Publicado: (2019)